Corruption tars drug industry drive to improve access for poor – report

The world's top drugmakers have improved access to medicines in developing countries, according to a report, but their good work is undermined by a sorry record of unethical behaviour. The Access to Medicines Index, which ranks the 20 leading pharmaceutical companies every two years on how well they get treatments to the poor, said the industry's progress had been "uneven". Eighteen of the firms monitored were the subject of settlements or fines for corrupt behaviour, unethical marketing or breaches of competition law in the last two years.

Read the story by Ben Hirschler, in Reuters.

Popular posts from this blog

The Pacific - Nepal - Eastern Europe & Central Asia

Middle East & North Africa - Ukraine - Sri Lanka

Global - Sub-Saharan Africa - Turkey & Syria